EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Grading Melanocytic Dysplasia: Updated Histopathologic Criteria

Christopher R Shea iD, Victor G Prieto iD, Catherine M Shachaf, Scott R Florell

Journal of Cutaneous Pathology · 2026

DOI: 10.1111/cup.14744 ↗

At a glance

Übersichtsarbeit in Journal of Cutaneous Pathology, 2026. Written by Christopher R Shea and 3 co-authors. Institution: Section of Dermatology, The University of Chicago Medicine, Chicago, Illinois, USA. Major MEDLINE topics: Skin Neoplasms, Dysplastic Nevus Syndrome, Melanocytes, Melanoma. Cited 5 times so far (Crossref); 21 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Dr. Martin C. Mihm, Jr.'s innovative work on the dysplastic nevus achieved a milestone in his chapter in the World Health Organisation Classification of Skin Tumours (WHO‐C). WHO‐C presents a dichotomous classification (high‐grade versus low‐grade dysplastic nevi) and a quantitative metric to assess melanocytic nuclear enlargement. The Duke classification is a related approach that provides mostly quantitative histopathologic criteria for dysplastic nevi and gives due weight to architectural features as well as cytology. This paper proposes and illustrates updated criteria for scoring and grading melanocytic dysplasia, incorporating some of the definitions and categories of WHO‐C, while refining the quantitative and architectural elements of the Duke grading system to facilitate more detailed and precise assessment of dysplastic nevi.

Subjects

MeSH terms (MEDLINE)

Skin NeoplasmsDysplastic Nevus SyndromeMelanocytesMelanomaHumansNeoplasm GradingWorld Health OrganizationNevus, Pigmented

Author keywords

dysplasiadysplasticgradingmelanocyticnevus

Authors and institutions

  • Section of Dermatology, The University of Chicago Medicine, Chicago, Illinois, USA.
  • Department of Pathology and Dermatology, Division of Pathology/Laboratory Medicine, University of Texas - MD Anderson Cancer Center, Houston, Texas, USA.
  • Orlucent, Inc., Los Gatos, California, USA.
  • Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.

ORCID profiles: Christopher R Shea, Victor G Prieto

Cite

APA

Shea, C. R., Prieto, V. G., Shachaf, C. M., & Florell, S. R. (2026). Grading Melanocytic Dysplasia: Updated Histopathologic Criteria. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14744

Vancouver

Shea CR, Prieto VG, Shachaf CM, Florell SR. Grading Melanocytic Dysplasia: Updated Histopathologic Criteria. Journal of Cutaneous Pathology. 2026. doi:10.1111/cup.14744

BibTeX
@article{Shea2026,
  author = {Shea, Christopher R and Prieto, Victor G and Shachaf, Catherine M and Florell, Scott R},
  title = {Grading Melanocytic Dysplasia: Updated Histopathologic Criteria},
  journal = {Journal of Cutaneous Pathology},
  year = {2026},
  doi = {10.1111/cup.14744}
}
Start for free →